白介素21(IL21)cDNA
cDNA of Interleukin 21 (IL21)
Za11
- 編號(hào)UCGB688Ra01
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 片段Met1~Ser146
- 適用宿主大腸桿菌
- 載體pET28a
- 酶切位點(diǎn)5'-NotI, 3'-XhoI
- 抗性卡那霉素
- 性狀凍干粉
- 應(yīng)用PCR、蛋白表達(dá)等
- 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 100ng
- 價(jià)格 ¥ 567
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
利用無(wú)菌水稀釋到10-100ng/ml.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月，-20°C不超過(guò)12個(gè)月。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Rattus norvegicus (Rat，大鼠) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| UAPB688Ra61 | 白介素21(IL21)活性蛋白 | Cell?culture;?Activity?Assays. |
| URPB688Ra01 | 白介素21(IL21)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAB688Ra01 | 白介素21(IL21)多克隆抗體 | WB; IHC; ICC; IP. |
| UMAB688Ra21 | 白介素21(IL21)單克隆抗體 | WB |
| USEB688Ra | 白介素21(IL21)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCB688Ra | 白介素21(IL21)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMB688Ra | 白介素21(IL21)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UCGB688Ra01 | 白介素21(IL21)cDNA | PCR、蛋白表達(dá)等 |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Neurological Sciences | Serum IL-21 levels decrease with glucocorticoid treatment in myasthenia gravis [Pubmed: 23708911] |
| Physiological Research Pre-Press Article | Decrease in serum interleukin 21 levels is associated with disease activity improvement in patients with recent-onset rheumatoid arthritis [Biomed: Source] |
| BioMed Research International | Indoleamine 2, 3-Dioxygenase (IDO) Regulates Th17/Treg Immunity in Experimental IgA Nephropathy [] |
| Am J Transplant | Circulatory follicular helper T lymphocytes associate with lower incidence of CMV infection in kidney transplant recipients [34153157] |
| J Periodontol | Cytokine profile in serum and gingival crevicular fluid of children with inflammatory bowel disease: A case‐control study [34730850] |
留言咨詢
